Biopharmaceutical (biopharma) Blister Packaging - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB511246539

Publication Date:

November 8, 2024

Pages:

107

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Packaging [2]

Industry & Manufacturing [3]

Description:

The global market for Biopharmaceutical (biopharma) Blister Packaging was estimated to be worth US$ 16980 million in 2023 and is forecast to a readjusted size of US$ 23310 million by 2030 with a CAGR of 4.7% during the forecast period 2024-2030
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Biopharmaceutical (biopharma) Blister Packaging, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Biopharmaceutical (biopharma) Blister Packaging by region & country, by Type, and by Application.
The Biopharmaceutical (biopharma) Blister Packaging market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biopharmaceutical (biopharma) Blister Packaging.
麻豆原创 Segmentation
By Company
Bemis
MeadWestvaco Corp
Kl枚ckner Pentaplast
Constantia Flexibles
Tekni-plex
Honeywell
Amcor
CPH Group
Bilcare
Shanghai Haishun
Segment by Type:
PVC
Lidding Foils
Cold Form
PVDC
Segment by Application
Capsule Drug
Tablets Drug
Others Drug
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Biopharmaceutical (biopharma) Blister Packaging manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Biopharmaceutical (biopharma) Blister Packaging in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Biopharmaceutical (biopharma) Blister Packaging in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Biopharmaceutical (biopharma) Blister Packaging Product Introduction
1.2 Global Biopharmaceutical (biopharma) Blister Packaging 麻豆原创 Size Forecast
1.3 Biopharmaceutical (biopharma) Blister Packaging 麻豆原创 Trends & Drivers
1.3.1 Biopharmaceutical (biopharma) Blister Packaging Industry Trends
1.3.2 Biopharmaceutical (biopharma) Blister Packaging 麻豆原创 Drivers & Opportunity
1.3.3 Biopharmaceutical (biopharma) Blister Packaging 麻豆原创 Challenges
1.3.4 Biopharmaceutical (biopharma) Blister Packaging 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Biopharmaceutical (biopharma) Blister Packaging Players Revenue Ranking (2023)
2.2 Global Biopharmaceutical (biopharma) Blister Packaging Revenue by Company (2019-2024)
2.3 Key Companies Biopharmaceutical (biopharma) Blister Packaging Manufacturing Base Distribution and Headquarters
2.4 Key Companies Biopharmaceutical (biopharma) Blister Packaging Product Offered
2.5 Key Companies Time to Begin Mass Production of Biopharmaceutical (biopharma) Blister Packaging
2.6 Biopharmaceutical (biopharma) Blister Packaging 麻豆原创 Competitive Analysis
2.6.1 Biopharmaceutical (biopharma) Blister Packaging 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Biopharmaceutical (biopharma) Blister Packaging Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical (biopharma) Blister Packaging as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 PVC
3.1.2 Lidding Foils
3.1.3 Cold Form
3.1.4 PVDC
3.2 Global Biopharmaceutical (biopharma) Blister Packaging Sales Value by Type
3.2.1 Global Biopharmaceutical (biopharma) Blister Packaging Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Biopharmaceutical (biopharma) Blister Packaging Sales Value, by Type (2019-2030)
3.2.3 Global Biopharmaceutical (biopharma) Blister Packaging Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Capsule Drug
4.1.2 Tablets Drug
4.1.3 Others Drug
4.2 Global Biopharmaceutical (biopharma) Blister Packaging Sales Value by Application
4.2.1 Global Biopharmaceutical (biopharma) Blister Packaging Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Biopharmaceutical (biopharma) Blister Packaging Sales Value, by Application (2019-2030)
4.2.3 Global Biopharmaceutical (biopharma) Blister Packaging Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Biopharmaceutical (biopharma) Blister Packaging Sales Value by Region
5.1.1 Global Biopharmaceutical (biopharma) Blister Packaging Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Biopharmaceutical (biopharma) Blister Packaging Sales Value by Region (2019-2024)
5.1.3 Global Biopharmaceutical (biopharma) Blister Packaging Sales Value by Region (2025-2030)
5.1.4 Global Biopharmaceutical (biopharma) Blister Packaging Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Biopharmaceutical (biopharma) Blister Packaging Sales Value, 2019-2030
5.2.2 North America Biopharmaceutical (biopharma) Blister Packaging Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Biopharmaceutical (biopharma) Blister Packaging Sales Value, 2019-2030
5.3.2 Europe Biopharmaceutical (biopharma) Blister Packaging Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Biopharmaceutical (biopharma) Blister Packaging Sales Value, 2019-2030
5.4.2 Asia Pacific Biopharmaceutical (biopharma) Blister Packaging Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Biopharmaceutical (biopharma) Blister Packaging Sales Value, 2019-2030
5.5.2 South America Biopharmaceutical (biopharma) Blister Packaging Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Biopharmaceutical (biopharma) Blister Packaging Sales Value, 2019-2030
5.6.2 Middle East & Africa Biopharmaceutical (biopharma) Blister Packaging Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Biopharmaceutical (biopharma) Blister Packaging Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Biopharmaceutical (biopharma) Blister Packaging Sales Value
6.3 United States
6.3.1 United States Biopharmaceutical (biopharma) Blister Packaging Sales Value, 2019-2030
6.3.2 United States Biopharmaceutical (biopharma) Blister Packaging Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Biopharmaceutical (biopharma) Blister Packaging Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Biopharmaceutical (biopharma) Blister Packaging Sales Value, 2019-2030
6.4.2 Europe Biopharmaceutical (biopharma) Blister Packaging Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Biopharmaceutical (biopharma) Blister Packaging Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Biopharmaceutical (biopharma) Blister Packaging Sales Value, 2019-2030
6.5.2 China Biopharmaceutical (biopharma) Blister Packaging Sales Value by Type (%), 2023 VS 2030
6.5.3 China Biopharmaceutical (biopharma) Blister Packaging Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Biopharmaceutical (biopharma) Blister Packaging Sales Value, 2019-2030
6.6.2 Japan Biopharmaceutical (biopharma) Blister Packaging Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Biopharmaceutical (biopharma) Blister Packaging Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Biopharmaceutical (biopharma) Blister Packaging Sales Value, 2019-2030
6.7.2 South Korea Biopharmaceutical (biopharma) Blister Packaging Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Biopharmaceutical (biopharma) Blister Packaging Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Biopharmaceutical (biopharma) Blister Packaging Sales Value, 2019-2030
6.8.2 Southeast Asia Biopharmaceutical (biopharma) Blister Packaging Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Biopharmaceutical (biopharma) Blister Packaging Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Biopharmaceutical (biopharma) Blister Packaging Sales Value, 2019-2030
6.9.2 India Biopharmaceutical (biopharma) Blister Packaging Sales Value by Type (%), 2023 VS 2030
6.9.3 India Biopharmaceutical (biopharma) Blister Packaging Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Bemis
7.1.1 Bemis Profile
7.1.2 Bemis Main Business
7.1.3 Bemis Biopharmaceutical (biopharma) Blister Packaging Products, Services and Solutions
7.1.4 Bemis Biopharmaceutical (biopharma) Blister Packaging Revenue (US$ Million) & (2019-2024)
7.1.5 Bemis Recent Developments
7.2 MeadWestvaco Corp
7.2.1 MeadWestvaco Corp Profile
7.2.2 MeadWestvaco Corp Main Business
7.2.3 MeadWestvaco Corp Biopharmaceutical (biopharma) Blister Packaging Products, Services and Solutions
7.2.4 MeadWestvaco Corp Biopharmaceutical (biopharma) Blister Packaging Revenue (US$ Million) & (2019-2024)
7.2.5 MeadWestvaco Corp Recent Developments
7.3 Kl枚ckner Pentaplast
7.3.1 Kl枚ckner Pentaplast Profile
7.3.2 Kl枚ckner Pentaplast Main Business
7.3.3 Kl枚ckner Pentaplast Biopharmaceutical (biopharma) Blister Packaging Products, Services and Solutions
7.3.4 Kl枚ckner Pentaplast Biopharmaceutical (biopharma) Blister Packaging Revenue (US$ Million) & (2019-2024)
7.3.5 Constantia Flexibles Recent Developments
7.4 Constantia Flexibles
7.4.1 Constantia Flexibles Profile
7.4.2 Constantia Flexibles Main Business
7.4.3 Constantia Flexibles Biopharmaceutical (biopharma) Blister Packaging Products, Services and Solutions
7.4.4 Constantia Flexibles Biopharmaceutical (biopharma) Blister Packaging Revenue (US$ Million) & (2019-2024)
7.4.5 Constantia Flexibles Recent Developments
7.5 Tekni-plex
7.5.1 Tekni-plex Profile
7.5.2 Tekni-plex Main Business
7.5.3 Tekni-plex Biopharmaceutical (biopharma) Blister Packaging Products, Services and Solutions
7.5.4 Tekni-plex Biopharmaceutical (biopharma) Blister Packaging Revenue (US$ Million) & (2019-2024)
7.5.5 Tekni-plex Recent Developments
7.6 Honeywell
7.6.1 Honeywell Profile
7.6.2 Honeywell Main Business
7.6.3 Honeywell Biopharmaceutical (biopharma) Blister Packaging Products, Services and Solutions
7.6.4 Honeywell Biopharmaceutical (biopharma) Blister Packaging Revenue (US$ Million) & (2019-2024)
7.6.5 Honeywell Recent Developments
7.7 Amcor
7.7.1 Amcor Profile
7.7.2 Amcor Main Business
7.7.3 Amcor Biopharmaceutical (biopharma) Blister Packaging Products, Services and Solutions
7.7.4 Amcor Biopharmaceutical (biopharma) Blister Packaging Revenue (US$ Million) & (2019-2024)
7.7.5 Amcor Recent Developments
7.8 CPH Group
7.8.1 CPH Group Profile
7.8.2 CPH Group Main Business
7.8.3 CPH Group Biopharmaceutical (biopharma) Blister Packaging Products, Services and Solutions
7.8.4 CPH Group Biopharmaceutical (biopharma) Blister Packaging Revenue (US$ Million) & (2019-2024)
7.8.5 CPH Group Recent Developments
7.9 Bilcare
7.9.1 Bilcare Profile
7.9.2 Bilcare Main Business
7.9.3 Bilcare Biopharmaceutical (biopharma) Blister Packaging Products, Services and Solutions
7.9.4 Bilcare Biopharmaceutical (biopharma) Blister Packaging Revenue (US$ Million) & (2019-2024)
7.9.5 Bilcare Recent Developments
7.10 Shanghai Haishun
7.10.1 Shanghai Haishun Profile
7.10.2 Shanghai Haishun Main Business
7.10.3 Shanghai Haishun Biopharmaceutical (biopharma) Blister Packaging Products, Services and Solutions
7.10.4 Shanghai Haishun Biopharmaceutical (biopharma) Blister Packaging Revenue (US$ Million) & (2019-2024)
7.10.5 Shanghai Haishun Recent Developments
8 Industry Chain Analysis
8.1 Biopharmaceutical (biopharma) Blister Packaging Industrial Chain
8.2 Biopharmaceutical (biopharma) Blister Packaging Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Biopharmaceutical (biopharma) Blister Packaging Sales Model
8.5.2 Sales Channel
8.5.3 Biopharmaceutical (biopharma) Blister Packaging Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Bemis
MeadWestvaco Corp
Kl枚ckner Pentaplast
Constantia Flexibles
Tekni-plex
Honeywell
Amcor
CPH Group
Bilcare
Shanghai Haishun

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.